Skip To Main Content
Xiushan Yin on Muck Rack

Xiushan Yin

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiushan

Contact Xiushan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Engineered human mesenchymal stem cells as new vaccine platform for COVID-19

|
By Junhua Liu, Huping Jiao, Xiushan Yin
| BioRxiv
Abstract Recently, there are several routes for COVID-19 vaccine research, yet their weaknesses lie in low efficiency, tolerability, immune adaptability and safety. We describe a new approach to COVID-19 based on engineered human mesenchymal stem cells (hu-MSC), which is like a small protein antigen response device, but will be gradually cleared and degraded by body' s immune system among recognization process. The antibody response results show that this is effective and fast.
Open in Who Shared Issue with article?
See all 1 articles